Delivery Order SPE2DE24D0021-SPE2D626F152A

Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,198.16 by the Department of Defense's Medical Supply Chain for benzodiazepine toxicology reagents, with an ultimate completion date of November 20, 2025. The award, issued on November 13, 2025, utilizes a fixed-price contract with economic price adjustment provisions and carries no set-aside designation, indicating open competition. This delivery order is a child contract under a larger Blanket Purchase Agreement established with the Department of Veterans Affairs' Veterans Integrated Service Network 1 (VISN 1) on October 1, 2025, which provides a $1.65 million ceiling for toxicology and drugs of abuse reagents and supplies through September 30, 2030. The parent agreement operates under the General Services Administration's Multiple Award Schedule, establishing pre-negotiated pricing and terms that enable rapid procurement of laboratory supplies across VISN 1's eleven facilities in the Northeastern United States.

Fisher Scientific, a major federal vendor headquartered in Pittsburgh, Pennsylvania, specializes in scientific products, laboratory equipment, and medical supplies. The company has maintained an extensive federal contract portfolio spanning the Department of Veterans Affairs, Department of Defense, National Institutes of Health, Indian Health Service, and other civilian agencies, with prior awards ranging from routine consumable orders to significant equipment purchases exceeding $400,000. Fisher Scientific's established credibility as a preferred supplier and demonstrated capacity to reliably deliver specialized laboratory reagents and supplies supporting federal healthcare and diagnostic operations make it well-positioned to fulfill this benzodiazepine toxicology reagent requirement supporting DoD medical supply chain operations.